Used in the pharmaceutical industry as an intermediate in the synthesis of anticoagulant drugs. It plays a key role in the production of potent platelet aggregation inhibitors, helping to prevent blood clot formation in cardiovascular treatments. Due to its chiral structure, it contributes to the selectivity and efficacy of the final drug compound, improving metabolic stability and target specificity. It is particularly valuable in developing therapies for patients at risk of stroke or myocardial infarction.